Guided Therapeutics (GTHP) Gross Margin (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1,929.00 |
| Sep 30, 2025 | -919.00 |
| Mar 31, 2024 | 1,667.00 |
| Jun 30, 2023 | -3,409.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 1,167.00 |
| Dec 31, 2021 | 18,939.00 |
| Sep 30, 2021 | -22,105.00 |
| Dec 31, 2020 | 25,558.00 |
| Dec 31, 2019 | -2,500.00 |
| Sep 30, 2019 | 650,000.00 |
| Jun 30, 2019 | -649,444.00 |
| Mar 31, 2019 | 19,921.00 |
| Dec 31, 2018 | -20,476.00 |
| Sep 30, 2018 | 1,250.00 |
| Jun 30, 2018 | 6,250.00 |
| Mar 31, 2018 | 23,808.00 |
| Dec 31, 2017 | -1,914.00 |
| Sep 30, 2017 | -19,969.00 |
| Jun 30, 2017 | -1,806.00 |
| Mar 31, 2017 | -1,508.00 |
| Dec 31, 2016 | 2,836.00 |
| Dec 31, 2015 | 398,889.00 |
| Sep 30, 2015 | -56,000.00 |
| Jun 30, 2015 | -117,333.00 |
| Mar 31, 2015 | 10,256.00 |
| Dec 31, 2014 | 2,168.00 |
| Sep 30, 2014 | 64,545.00 |
| Jun 30, 2014 | -26,794.00 |
| Mar 31, 2014 | -32,102.00 |
| Dec 31, 2013 | 2,121.00 |
| Sep 30, 2013 | -6,725.00 |
| Jun 30, 2013 | 1,422.00 |
| Mar 31, 2013 | -1,685.00 |
| Dec 31, 2012 | 302.00 |
| Sep 30, 2012 | 330.00 |
| Jun 30, 2012 | -9,528.00 |
| Mar 31, 2012 | -2,024.00 |
| Dec 31, 2011 | 1,833.00 |
| Sep 30, 2011 | -6.00 |
| Jun 30, 2011 | -139.00 |